Physical therapists continue to fight an uphill battle to gain equality on the healthcare playing field—long considered ancillary providers rather than primary providers within the healthcare ...

Clinical pathways remain ambiguous for much of oncology and its stakeholders. Adoption has been slow, and it is fraught with negotiations and push-back from providers. This could be due to a lack of ...

Medicare reimbursement is now value-based, requiring providers to demonstrate clinical excellence while managing costs efficiently. Traditional MIPS reporting often consumed hours on metrics that had ...

The integration of AI has the potential to enhance oncology clinical pathways, but there are important judgment calls that must be made before this technology can be fully implemented. The quest to ...

The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...